What is the diagnosis code for a new patient with no history of diabetes and a hemoglobin A1C (HbA1C) level of 10.2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis Code for New Patient with A1C 10.2% and No Prior Diabetes History

Use ICD-10 code E11.65 (Type 2 diabetes mellitus with hyperglycemia) for this patient, as the markedly elevated A1C of 10.2% definitively establishes a new diagnosis of diabetes mellitus. 1

Diagnostic Confirmation

  • An A1C of 10.2% far exceeds the diagnostic threshold of ≥6.5% for diabetes, corresponding to an estimated average glucose of approximately 246 mg/dL, which is significantly above the diagnostic cut-point. 2, 1

  • The diagnosis is confirmed with a single A1C test when the value is this markedly elevated (10.2%), particularly if the patient has classic symptoms of hyperglycemia (polyuria, polydipsia, weight loss) or if you obtain a confirmatory test. 1

  • If you want absolute certainty, repeat the A1C test or obtain a fasting plasma glucose to confirm the diagnosis, though with an A1C this elevated, the diagnosis is essentially certain. 1

Type Classification Considerations

The default diagnosis code should be Type 2 diabetes (E11.65) unless specific clinical features suggest Type 1 diabetes or other forms:

Features suggesting Type 2 diabetes (most likely in this case): 1

  • Age >35 years
  • BMI ≥25 kg/m²
  • Absence of weight loss
  • Absence of ketoacidosis at presentation
  • Less marked hyperglycemia symptoms
  • Features of metabolic syndrome

Features that would warrant investigation for Type 1 diabetes: 1

  • Age <35 years
  • Presence of diabetic ketoacidosis (DKA)
  • Significant unintentional weight loss
  • Severe hyperglycemic symptoms
  • Lean body habitus

If Type 1 diabetes is suspected, order islet autoantibodies (GAD, IA-2, ZnT8) and consider C-peptide testing to differentiate between Type 1 and Type 2 diabetes, though this can be done after initial coding and treatment initiation. 1

Clinical Urgency

This patient requires immediate intervention regardless of diabetes type, as an A1C of 10.2% indicates severe chronic hyperglycemia with increased risk for acute and chronic complications including retinopathy, nephropathy, neuropathy, and cardiovascular disease. 2

  • Assess for hyperglycemic crisis: Check for symptoms of DKA (nausea, vomiting, abdominal pain, altered mental status) or hyperosmolar hyperglycemic state, particularly if blood glucose is >270 mg/dL or ketones are present. 3

  • For A1C ≥10%, initiate insulin therapy immediately (basal insulin at 10 units or 0.1-0.2 units/kg body weight) along with metformin unless contraindicated, to rapidly achieve glycemic control. 2

Common Pitfalls to Avoid

  • Do not delay coding or treatment while waiting for additional confirmatory tests when A1C is this markedly elevated—the diagnosis is clear. 2

  • Do not use "prediabetes" codes (R73.03) when A1C is ≥6.5%, as this meets full diagnostic criteria for diabetes. 1

  • Be aware that A1C may be falsely low or high in conditions affecting red blood cell turnover (hemolysis, recent transfusion, hemoglobinopathies, iron deficiency anemia), though with an A1C of 10.2%, this is unlikely to change the diagnosis. 1, 3

  • Ensure the A1C was measured using an NGSP-certified method standardized to the DCCT assay; point-of-care A1C tests are not sufficiently accurate for diagnostic purposes. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Hyperglycemia in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperglycemia with Low HbA1c

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.